HCmed Innovations Co (TPE:6934) Operating Margin %: 5.90% (As of Dec. 2025)


TPE:6934 HCmed Innovations Co Ltd TPE:6934
11 GF Score
Price NT$68.00
! 4 Warning Signs
View Full Analysis

What is HCmed Innovations Co Operating Margin %?

HCmed Innovations Co TPE:6934 -2.16% 11 Operating Margin % is 5.90% as of Dec. 2025. GuruFocus rates TPE:6934 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, HCmed Innovations Co ranks worse than 74.85% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. HCmed Innovations Co's Operating Income for the three months ended in Dec. 2025 was NT$4.87 Mil. HCmed Innovations Co's Revenue for the three months ended in Dec. 2025 was NT$82.48 Mil. Therefore, HCmed Innovations Co's Operating Margin % for the quarter that ended in Dec. 2025 was 5.90%.

The historical rank and industry rank for HCmed Innovations Co's Operating Margin % or its related term are showing as below:

TPE:6934' s Operating Margin % Range Over the Past 10 Years
Min: -2253.83   Med: -119.37   Max: -26.55
Current: -36.91


TPE:6934's Operating Margin % is ranked worse than
74.85% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 3.41 vs TPE:6934: -36.91

HCmed Innovations Co's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

HCmed Innovations Co's Operating Income for the three months ended in Dec. 2025 was NT$4.87 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-32.99 Mil.


HCmed Innovations Co  (TPE:6934) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


HCmed Innovations Co Operating Margin % Related Terms


HCmed Innovations Co Operating Margin % Historical Data

* Premium members only.

The historical data trend for HCmed Innovations Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HCmed Innovations Co Operating Margin % Chart

HCmed Innovations Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
-75.60 -2,253.83 -1,556.60 -26.55 -119.37

HCmed Innovations Co Quarterly Data
Dec21 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -119.16 50.59 0.00 -548.73 5.90

TPE:6934 vs ABT, SYK, MDT: Operating Margin % Comparison

For the Medical Devices subindustry, HCmed Innovations Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HCmed Innovations Co Operating Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HCmed Innovations Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where HCmed Innovations Co's Operating Margin % falls into.


TPE:6934
11GF Score
HCmed Innovations Co Ltd TPE:6934
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HCmed Innovations Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

HCmed Innovations Co's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-119.652 / 100.234
=-119.37 %

HCmed Innovations Co's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=4.869 / 82.48
=5.90 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 5.90% mean?
HCmed Innovations Co (TPE:6934) has a Operating Margin % of 5.90% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on HCmed Innovations Co and its competitors. According to the industry distribution chart, HCmed Innovations Co ranks #610 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 74.8%.
Is HCmed Innovations Co's Operating Margin % too high?
HCmed Innovations Co's current Operating Margin % is 5.90%. The Medical Devices & Instruments industry median Operating Margin % is 3.41. HCmed Innovations Co's value of 5.90% is 73% above this industry median. Based on the distribution chart, HCmed Innovations Co ranks #610 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, HCmed Innovations Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does HCmed Innovations Co's Operating Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, HCmed Innovations Co ranks #610 out of 815 companies for Operating Margin %. This places HCmed Innovations Co in the lower half of its industry. The industry median Operating Margin % is 3.41. HCmed Innovations Co's value of 5.90% is 73% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.41, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HCmed Innovations Co's current Operating Margin % of 5.90% is 73% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on HCmed Innovations Co and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HCmed Innovations Co's current Operating Margin % is 5.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HCmed Innovations Co stock overvalued right now?
HCmed Innovations Co (TPE:6934) has a current Operating Margin % of 5.90%. The current Operating Margin % is 5.90% and 73% above the Medical Devices & Instruments industry median of 3.41. HCmed Innovations Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For HCmed Innovations Co (TPE:6934), the current Operating Margin % is 5.90% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HCmed Innovations Co Business Description

Address Dunhua S. Road, Rm.B, 10th floor., No.319, Sec.2, Taipei, TWN, 106033
HCmed Innovations Co Ltd is engaged in designing, developing, manufacturing and selling drug delivery system. It is focused on inhalation therapy to create integrated drug nebulizer combination products featuring nebulization therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. Its product includes Pulmogine. Geographically, the company operates in America, Europe, Asian and African regions.
11GF Score

Get the complete analysis for TPE:6934

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$68.00
Price